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ACQUIRED CARDIOVASCULAR DISEASEGraft patency after off-pump coronary artery bypass surgery is
inferior even with identical heparinization protocols: Results from
the Danish On-pump Versus Off-pump Randomization Study
(DOORS)KimHoulind, MD, PhD,a,b Morten Fenger-Grøn, MSc,c Susanne J. Holme, MD,d Bo J. Kjeldsen, MD, PhD,e
Susanne N. Madsen, MD,f Bodil S. Rasmussen, MD, PhD,g Mogens H. Jepsen, MD,a
Jan Ravkilde, MD, DMSc,h,i Jens Aaroe, MD, DMSc,h Peter Riis Hansen, MD, DMSc,j
Henrik Steen Hansen, MD, DMSc,k and Poul Erik Mortensen, MD,e for the DOORS Study GroupFrom th
Hosp
South
sity, A
Depa
ter fo
Unive
Hosp
Depa
Depa
diolog
This wo
Techn
John
trial w
pretat
Disclosu
other
Clinical
NCT0
Receive
public
Address
Koldi
(E-ma
0022-52
Copyrig
http://dx
1812Objective: To determine whether graft patency after on-pump and off-pump coronary artery bypass surgery is
similar when performed using the same heparinization protocol.
Methods: In a randomized, controlled, multicenter trial, 900 patients more than 70 years of age received either
on-pump or off-pump coronary artery bypass surgery. Heparin was given to achieve an activated clotting time of
400 seconds before arteriotomy in both groups. After the procedure, protamine sulfate was given to revert the
activated clotting time to less than 120 seconds. Coronary angiography was performed 6 months after the
operation and graft patency was assessed by independent blinded observers.
Results: A total of 481 patients underwent angiography. In the off-pump group, 561 (79%) of 710 grafts were
open, 65 (9%) were stenotic, and 84 (12%) were occluded. In the on-pump group, 549 (86%) of 650 grafts were
open, 38 (5%) were stenotic, and 63 (9%) were occluded. The difference between the proportion of open grafts
was statistically significant in favor of on-pump surgery (P ¼ .01). The proportion of open left internal thoracic
artery grafts was 95% in both groups. Perioperative use of intracoronary shunts did not increase the risk of
stenosis of the coronary artery distal to the anastomosis.
Conclusions: Despite comparable heparinization, graft patency after off-pump surgery was inferior to that after
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Coronary artery bypass grafting has traditionally been per-
formed with the use of cardiac arrest and extracorporeal car-
diopulmonary bypass (conventional coronary artery bypass
[CCABG]). However, some concern has been raised with
regard to the safety of CCABG. Since the mid-1990s, there-
fore, a significant proportion of coronary artery bypass
operations have been performed on the beating heart
(off-pump coronary artery bypass, OPCAB). It has been
suggested that the risk of perioperative stroke could be
reduced by avoiding manipulation of the aorta,1 although
this was not confirmed by recent large-scale trials.2-4
Smaller trials have documented a decreased inflammatory
response,5-7 less bleeding,8-10 lower risk of atrial
fibrillation,8 smaller release of biochemical markers of
myocardial injury,10-12 and lower costs13-15 related to
OPCAB compared with CCABG.
On the other hand, the efficacy of OPCAB has been ques-
tioned. Most studies2-4,14 have found that OPCAB patients
receive fewer grafts and that a lower proportion ofgery c November 2014
Abbreviations and Acronyms
ACT ¼ activated clotting time
CCAB ¼ conventional coronary artery bypass
DOORS ¼ Danish On-pump Versus Off-pump
Randomization Study
LAD ¼ left anterior descending
ITA ¼ internal thoracic artery
LVEF ¼ left ventricular ejection fraction
OPCAB ¼ off-pump coronary artery bypass
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DOPCAB patients are fully revascularized compared with
CCABG patients. Several studies have also shown poorer
graft patency at follow-up after OPCAB.3,14,16-18
Several differences between off-pump and on-pump sur-
gery may contribute to a lower graft patency in off-pump
patients. The on-pump technique offers a bloodless, immo-
bile field for performing the anastomoses, whereas OPCAB
surgery is more technically challenging. Also, although car-
diopulmonary bypass is a cause for hemodilution and
platelet dysfunction, a hypercoagulable state may be pre-
sent in patients after OPCAB surgery.19-21 Despite this
observation, most centers give lower intraoperative doses
of heparin for OPCAB than CCABG.22,23 In this regard, it
is interesting that Uva and colleagues18 in a randomized
controlled trial, found a significantly lower crude graft
patency rate after off-pump surgery compared with on-
pump surgery, but failed to find a significant difference after
adjusting for heparin dose.
A drawback of the earlier studies is the lack of control of
antiplatelet therapy. Randomized trials point toward a clin-
ical benefit of clopidogrel in addition to aspirin after sur-
gery, especially for OPCAB patients.24 This treatment
(clopidogrel) was either not used, not controlled for, or
not reported in the earlier trials.2,3,9,14,18
The Danish On-pump Off-pump Randomization Study
(DOORS) comprised 900 patients of more than 70 years of
age.4,25 To exclude the effects of different heparinization
protocols and differences in antiplatelet therapy, both these
treatments were standardized and identical in the 2 study
groups. The aim of the current study was to examine
whether graft patency after off-pump surgery was equal to
the results for on-pump surgery.
METHODS
Design and Participants
Details of the design of the DOORS study have been given elsewhere.25
The names of the investigators are listed in Appendix E1. Nine hundred pa-
tients who were 70 years of age or older and who were admitted for
nonemergency surgical revascularization at 1 of the 4 participating centers
were consecutively screened for participation in the study (Figure 1). All
participating surgeons were consultants experienced in multivessel
CCABG and OPCAB surgery. Each had previously performed a minimum
of 25 OPCAB operations with grafts to the circumflex territory beforeThe Journal of Thoracic and Carentering the study. Trainees were not allowed to be the primary surgeon
for any procedure.
Consent and Inclusion Procedure
The patients gave written consent after provision of written and oral in-
formation. The study protocol was approved by the local ethics committee.
Randomization and Masking
Online randomization was performed. Block randomization was per-
formed in blocks of 6 stratified by treating center. Treatment was not
masked. Before randomizing, the surgeon responsible was requested to
submit a plan indicating the specific target vessels to be grafted.
Interventions
Anesthesia, cardiopulmonary bypass, surgery, and postoperative care
were performed according to detailed protocols.25 All operations were per-
formed through a full median sternotomy, and all patients in the CCABG
group were operated with aortic crossclamping and cardioplegic arrest.
For OPCAB, exposure was achieved with deep pericardial anchoring su-
tures fixing a supporting gauze and using both apical and local stabilizing
suction devices (Octopus Tissue Stabilizer; Medtronic Inc, Minneapolis,
Minn) or CTS Axius Guidant Stabilizer System (Guidant Corporation,
Santa Clara, Calif). Use of intracoronary shunts was favored when this
was technically possible. Application of coronary occlusion snares was
permitted within the protocol only proximal, not distal, to the anastomotic
site. The use of shunts or snares was only applied for OPCAB patients.
Graft patency was assessed at the end of the procedure using a
Transit Time Flow Meter (Medistim, Oslo, Norway). A revision was per-
formed if the flow or pulsatility index was deemed unacceptable by the
surgeon.
All patients were treated with clopidogrel 75 mg/d for 3 months postop-
eratively, except for patients treated with coumarins for other indications.
Statins and acetyl salicylic acid were given to all patients unless specif-
ically contraindicated.
For both OPCAB and CCABG operations, heparin was given at a dose
sufficient to achieve an activated clotting time (ACT) of 400 seconds before
opening the pericardium. For OPCAB operations, the anticoagulation was
reverted using protamine sulfate until the ACT was brought back to less
than 120 seconds after performing the anastomoses. Similarly, for CCABG
operations, heparinization was reverted using protamine to an ACT level of
less than 120 seconds after decannulation.Follow-up
Six months after surgery, patients were invited to have a control coro-
nary angiography. An attempt was made to inject contrast and visualize
all grafts in 2 orthogonal planes after administration of nitroglycerin. All
examinations were assessed in a blinded manner by 2 of 4 experienced in-
terventional cardiologists (J.R., J.A, P.R.H., H.S.H.), who assessed the
proximal anastomosis, the shaft of the graft, and the distal anastomosis,
and rated it according to the FitzGibbon criteria26 as A (open), B (>50%
stenotic), or O (occluded), or as ‘‘not sufficiently well visualized to
decide.’’ To evaluate whether the use of proximal snares or intracoronary
shunts caused damage to the native coronary vessels, the section of the
coronary artery 1 cm proximal and 1 cm distal to the anastomosis was
also assessed. Controversies were settled by conference.Statistics
When comparing graft patency between OPCAB and CCABG patients,
the least favorable grading of either the proximal anastomosis, the shaft, or
the distal anastomosis was used. For example, a graft with a FitzGibbon
grading of B for the proximal anastomosis, A for the shaft, and A for the
distal anastomosis received an overall B grade.26diovascular Surgery c Volume 148, Number 5 1813
FIGURE 1. Study flowchart. CCABG, Conventional coronary artery bypass grafting; OPCAB, off-pump coronary artery bypass.
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DWhen comparing the number of grafts performed and the number of
grafts planned, the Wilcoxon signed rank test was applied. For comparison
of baseline characteristics and secondary end points, the Pearson c2 test
(P), the Mann-Whitney rank test (r), or the Fisher exact test (F) was used
as appropriate.
Crude and adjusted risk differences were calculated between OPCAB
or CCABG, depending on whether revision of anastomosis was required
or not, coronary vessel territory, graft material, type of proximal anasto-
mosis, and position in sequencing grafts. The differences were assessed
using a binomial regression model; that is, a generalized linear model
from the Bernoulli family using identity links. Cluster-robust variance
estimation was performed to account for the expected dependence be-
tween vessels within the same patient. In an additional post hoc analysis,
the use of proximal snaring and intracoronary shunts was also included.
An analysis of the propensity to choose to have follow-up angiography
with inclusion of key variables was performed. Analyses were performed
according to intention to treat using STATA (Stata Corporation, College
Station, Tex).RESULTS
The baseline clinical characteristics of the patients who
underwent coronary angiography at 6 months follow-up
are given in Table 1. The corresponding data for the entire1814 The Journal of Thoracic and Cardiovascular Surgroup of enrolled patients have been reported earlier.4
Compared with the patient groups enrolled originally, a
higher proportion of male patients (59% vs 42%) and a
higher proportion of OPCAB patients (58% vs 51%) un-
derwent the coronary angiography. The groups examined
were, however, balanced with regard to age, comorbidities,
and use of medication. A total of 57 patients assigned to
OPCAB were converted to CCABG. All conversions were
performed before the undertaking any anastomoses. The
reasons were hemodynamic instability (n ¼ 27) or diffi-
culties with exposure of coronary vessels (n ¼ 30). Twelve
patients had their operations converted from CCABG to
OPCAB, all because of heavily calcified aortas.Mortality
Six months after surgery, mortality was 21 (4.7%) in the
on-pump group and 19 (4.2%) in the off-pump group
(P ¼ .75). Causes of mortality were not recorded, but 3 of
the CCABG patients and 1 of the OPCAB patients who
died within the 6-month follow-up period had a strokegery c November 2014
TABLE 1. Risk factors and comorbidities
CCABG
(n ¼ 226)
OPCAB
(n ¼ 255) P value
Age, median y (IQR) 75 (72-78) 74 (72-77) .21 (r)
Male sex,% 84 81 .48 (P)
Left main stenosis>50%,% 43 51 .10 (P)
One-vessel disease,% 2 3
Two-vessel disease,% 21 16
Three-vessel disease,% 76 81 .30 (r)
LVEF,%
50% 70 73
30%,<50% 25 23
<30% 6 5 .76 (r)
Previous MI,%
Within 90 d before operation 23 23
Earlier than 90 d before
operation
23 19
Never 54 58 .59 (P)
Neurologic dysfunction,% 4 5 .88 (P)
COPD,% 7 7 .86 (P)
PVD,% 12 11 .96 (P)
Previous percutaneous coronary
intervention,%
15 17 .51 (P)
Diabetes,% 16 22 .15 (P)
Hypertension (medicated),% 70 68 .69 (P)
Atrial fibrillation,% 6 5 .90 (P)
Smoking,%
Current 23 26
Previous 57 47
Never 20 27 .09 (r)
Obesity (BMI>30kg/m2),% 22 20 .50 (P)
Hemoglobin, median mmol/L
(IQR)
8.4 (8.0-9.0) 8.6 (8.0-9.1) .22 (r)
Serum creatinine, median
mmol/L (IQR)
94 (82-111) 94 (81-109) .55 (r)
Unstable angina (nitro-iv),% 1 3 .14 (P)
Medication,%
Aspirin 90 94 .11 (P)
b-Blockers 75 76 .67 (P)
Statins 89 89 .96 (P)
ACE inhibitors 45 42 .49 (P)
Calcium antagonists 36 33 .61 (P)
Nitrates 45 46 .87 (P)
Diuretics 41 39 .67 (P)
Coumarins 15 15 .87 (P)
Digitalis 4 5 .31 (P)
Clopidogrel 37 32 .25 (P)
Antiarrythmics 4 6 .26 (P)
IQR, Interquartile range; LVEF, left ventricular ejection fraction; MI, myocardial
infarction; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular
disease; BMI, body mass index; ACE, angiotensin-converting enzyme; CCABG,
conventional coronary artery bypass grafting; OPCAB, off-pump coronary artery
bypass.
FIGURE 2. Number of realized grafts as percentages of the number of
preoperatively projected grafts divided in treatment groups and coronary
territories. Anterior: Left anterior descending artery territory, Right: Right
coronary artery territory, Circumflex: Circumflex artery territory. CCABG,
Conventional coronary artery bypass grafting;OPCAB, off-pump coronary
artery bypass.
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patients and 5 of the OPCAB patients who died within the
6-month follow-up period had a myocardial infarction
within the first 30 postoperative days.The Journal of Thoracic and CarNumber of Grafts
The preoperative plans stipulated 1408 grafts in the
CCABG group and 1441 in the OPCAB group. A total of
1383 grafts were performed in the CCABG patients and
1309 in the OPCAB patients (between-group comparison
of the number of grafts performed compared with the num-
ber of grafts planned, P ¼ .039). As shown in Figure 2, this
tendency toward fewer grafts being performed at OPCAB
operations was present for all coronary territories. The pro-
portion of patients who received fewer grafts than planned
was 32% among OPCAB patients who underwent angio-
graphic follow-up and 36% among those who did not
undergo this examination. For the CCABG group, the num-
ber was 17% irrespective of whether they underwent
follow-up angiography or not (P ¼ .69).Graft Patency
After 6 months, 481 patients (56% of the 860 survivors)
underwent control angiography. A total of 1475 grafts were
cannulated and 1360 grafts were visualized well enough for
the cardiologists to reach a decision on graft patency.
Among OPCAB patients, 710 grafts were graded and of
these, 561 (79%) were graded as open, 65 (9%) were ste-
notic, and 84 (12%) were occluded. In the CCABG group,
549 (86%) of 650 grafts were open, 38 (5%) were stenotic,diovascular Surgery c Volume 148, Number 5 1815
FIGURE 3. Percentage of occluded, stenotic, and open grafts in each territory. CCABG, Conventional coronary artery bypass grafting;OPCAB, off-pump
coronary artery bypass. Anterior: Left anterior descending artery territory; Right: Right coronary artery territory; Circumflex: Circumflex artery territory.
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tween the number of totally occluded grafts did not reach
statistical significance (P ¼ .20), the difference between
the fraction of open (ie, nonoccluded) and nonstenotic
grafts was statistically significant in favor of CCABG
(P ¼ .01).
Graft patencies for each coronary territory are shown
in Figure 3. Grafts to the anterior territory had high patency,
whereas the patency of grafts to the circumflex and right ter-
ritories was lower and with a larger difference between
groups favoring CCABG.
In the 250 stenotic or occluded grafts, the obstruction was
observed at 121 proximal anastomoses, 65 shafts, and 96
distal anastomoses. In a high proportion of grafts with
obstruction at the proximal anastomosis, the shaft and the
distal anastomosis were graded as being ‘‘not sufficiently
well visualized to decide.’’
As reported earlier, a total of 62 myocardial infarctions
were diagnosed by the independent end point committee
in the DOORS study.4 A total of 30 of these patients (19 ran-
domized to OPCAB) underwent the follow-up coronary
angiography at 6 months. Eleven OPCAB patients and 5
CCABG patients with myocardial infarction had at least 1
documented occluded graft. All the myocardial infarctions
associated with documented occluded grafts occurred
within 24 hours of surgery, except for 1 patient, who was
diagnosed with myocardial infarction in the interval be-
tween 1 and 30 days after surgery.
The proportion of nonoccluded left internal thoracic ar-
tery grafts was 95% in both groups, with higher proportions
of stenotic and occluded vein grafts and grafts of the radial
artery or right internal thoracic artery.1816 The Journal of Thoracic and Cardiovascular SurA perioperative revision of the anastomosis was per-
formed in 45 cases among the 1360 grafts that were later
visualized. Eleven of these grafts (24%) were either ste-
notic or occluded at follow-up. This figure was not statisti-
cally different from the fate at follow-up of the grafts in
which no revision was performed (P ¼ .32).Native Coronary Arteries
The native vessel was stenotic or closed 1 cm proximal to
the anastomosis site in 58 of 177 cases (33%) in which a
proximal snare was applied during surgery and in 253 of
978 cases (26%) in which it was not applied (P ¼ .06).
With regard to the use of intracoronary shunts, the native
vessel was stenotic or occluded proximal to the anastomosis
in 140 of 470 cases (30%) in which a shunt was applied
versus 172 of 684 cases (34%) in which it was not applied
(P ¼ .08), and 1 cm distal to the anastomosis in 40 of 475
cases (8%) after application of a shunt compared with 48
of 688 cases (7%) in which a shunt was not used (P¼ .44).Binomial Regression Analysis
The results of the binomial regression model are given in
Table 2. This analysis confirmed that graft patencywas infe-
rior in OPCAB patients compared with CCABG patients.
Pedicled grafts performed better in terms of graft patency
at follow-up than grafts with a proximal anastomosis on
the aorta. Conversely, Y grafts tended to perform worse,
although this difference was not statistically significant
(P ¼ .09). From the crude data analysis, single grafts per-
formed better than sequential grafts, but this difference
was less apparent after taking into account that sequentialgery c November 2014
TABLE 2. Risk difference analysis for graft obstruction, defined as either stenosis>50% or occlusion
N Obstructed (%)
Crude analysis Multiply adjusted analysis
RD CI low CI upper P value RD CI low CI upper P value
CCABG 650 15.5 (ref) (ref)
OPCAB 710 21.0 5.4 0.9 10.0 .02 4.6 3.8 8.8 .033
Territory
LAD 643 14.4 (ref) (ref)
Cx 318 21.7 7.2 2.0 12.4 .01 5.3 1.5 12.2 .128
RCA 399 22.1 7.6 3.1 12.1 .001 4.4 1.1 9.9 .118
Proximal anastomosis site
Aorta 648 19.6 (ref) (ref)
Y graft 251 27.1 7.5 0.7 14.3 .03 6.8 1.1 14.8 .09
Pedicled 461 12.0 7.7 12.3 3.1 .001 13.6 19.6 7.6 <.001
Graft material
Saphenous vein 694 20.2 (ref) (ref)
Radial artery 176 25.0 4.8 2.9 12.6 .22 1.7 8.2 4.8 .48
Left internal thoracic artery 454 12.6 7.6 12.1 3.1 .001 11.1 7.5 14.7 <.001
Right internal thoracic artery 36 25.0 4.8 10.0 19.6 .52 9.8 2.5 22.2 .12
Single graft 649 14.5 (ref) (ref)
Sequential graft, second anastomosis 314 22.9 8.4 3.1 13.8 .002 6.7 0.5 13.0 .034
Sequential graft, third anastomosis 269 18.6 4.1 1.2 9.4 .13 0.8 7.1 5.5 .072
Sequential graft,>third anastomosis 128 26.6 12.1 4.2 19.8 .002 5.0 3.7 13.9 .26
No revision 1315 18.2 (ref) (ref)
Revision 45 24.4 6.3 6.2 18.7 .324 6.3 4.9 17.6 .27
RD, Risk difference (%);CI, confidence interval;CCABG, conventional coronary artery bypass grafting;OPCAB, off-pump coronary artery bypass; LAD, left anterior descending
artery; Cx, circumflex artery; RCA, right coronary artery.
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nary artery territories, where the patency tended to be infe-
rior to that in the left anterior descending (LAD) territory. In
the crude data analysis, the left internal thoracic artery
(ITA) graft patency was significantly better than the other
graft materials, but this was not the case after correcting
for the fact that it was almost exclusively used for the
more favorable LAD territory. In the post hoc analysis,
the use of shunts did not significantly increase the risk of
graft obstruction (risk difference 1.1%, 95% confidence in-
terval, 5.0% to 7.4%, P ¼ .71).
The propensity to attend the follow-up angiography was
unevenly distributed among groups. In a logistic regression
analysis including the randomization group, age, sex, left
main coronary artery disease, left ventricular ejection frac-
tion (LVEF), triple vessel disease, previous myocardial
infarction, diabetes, hypertension, and smoking status,
male patients were more prone to attend the follow-up
(odds ratio, 0.53; 95% CI, 0.38-0.73, P < .001). For
OPCAB patients, younger patients, and patients with
LVEF greater than 50%, similar but weaker tendencies
toward more frequent attendance were observed, all at a
standard significance level less than 5% but not sufficiently
marked to hold significance when corrected for multiple
testing.
To account for this, the standard analyses of differences
in risk of occlusion were supplemented by propensity-
weighted analyses, in which the propensity to attendThe Journal of Thoracic and Carfollow-up was estimated using 2 different logistic models:
1 including all the abovementioned factors (Table E1,
part A) and 1 including all the abovementioned factors
and allowing interaction between the randomization group
and the other factors (Table E1, part B). No post hoc elim-
ination for nonsignificance was performed.
Propensity weighting entailed a slightly lower overall
estimate of graft patency. This is not unexpected, because
some of the preoperative characteristics predicting atten-
dance (low age, high LVEF) are also plausible predictors
for graft patency. However, as the implied selection was
not double skewed with respect to the perioperative param-
eters studied, accounting for propensity to attend follow-up
did not affect the overall results or conclusions.
DISCUSSION
Follow-up angiographic data from 1 of the largest ran-
domized comparisons of OPCAB and CCABG is presented.
Through a uniform protocol, potential effects caused by dif-
ferences in heparinization protocols in earlier studies were
eliminated. We hypothesized that this design would
improve graft patency in the OPCAB group by lessening
the degree of hypercoagulability. However, contrary to
our expectations, we found that graft patency was poorer
after OPCAB compared with CCABG.
Several randomized studies have confirmed that lower
graft patency results from OPCAB compared with CCABG
surgery, although these studies did not account sufficientlydiovascular Surgery c Volume 148, Number 5 1817
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study, impaired graft patency was most evident when not
only considering the proportion of totally occluded grafts
but also the number of stenotic grafts by using the
FitzGibbon score,26 as also seen in the ROOBY trial.16
Although graft occlusion may, theoretically, be caused by
hypercoagulability, stenosis is more likely to be caused by
technical anastomotic issues and operator experience has
been suggested to be an important variable for graft patency
after OPCAB. Undoubtedly, performing an anastomosis on
a beating heart is more technically challenging than on the
cardioplegic heart and may require a longer learning curve.
In particular, performing the anastomosis to the circumflex
area of the heart during OPCAB requires experience. In the
present study, the participating surgeons were required to
have performed at least 25 OPCAB procedures involving
grafts to the circumflex area before being certified to partic-
ipate. Specifically, 10 of the 12 participating surgeons had
performed more than the 100 OPCAB procedures that
were required to participate in the CORONARY study and
we consider it likely that their learning curve had reached
a plateau and that our findings were caused by inherent
weakness of the OPCAB procedure rather than by inexperi-
ence of the surgeons.
We confirm the findings from earlier trials reporting
lower graft patency as well as fewer grafts being performed
with OPCAB than with CCABG surgery.14,16-18 At present,
it is not clear whether this difference has effects on patient
symptoms, life expectancy, or quality of life. Long-term
follow-up from more studies is warranted to elucidate this
question. However, the fact that the ROOBY investigators
found a higher risk of cardiac death within 1 year postoper-
atively in patients operated with OPCAB compared with
CCABG,3 as well as a higher risk of cardiovascular events
in patients with occluded grafts,16 are causes for concern.
The same applies to the finding of a higher need for coro-
nary reinterventions in the OPCAB groups of the both the
CORONARY and ROOBY trials.16,18 Perioperative
myocardial infarctions may be caused either by graft
dysfunction or by inadequate perioperative myocardial
protection. In the present study, graft occlusion tended to
be more frequent in patients who had a myocardial
infarction after OPCAB than in patients who had a
myocardial infarction after CCABG, possibly pointing
toward different infarct mechanisms.
The use of a looped prolene suture or silicone snare to
occlude the target coronary artery distally to the anasto-
mosis has been suspected to cause damage to the vessel.27
In the post hoc multivariate analysis including use of snares
and shunts, the use of a proximal snare was an independent
predictor of graft failure. We believe that this difference
may be caused, in part, by selection bias as surgeons tend
to use the proximal occlusion technique in cases where a
large amount of competitive flow is present and the latter1818 The Journal of Thoracic and Cardiovascular Suris known to be a predictor of graft occlusion.28 Although
experimental studies and human studies using scanning
electron microscopy have shown that the use of intracoro-
nary shunts causes damage to the coronary endothelium,29
the present study did not indicate that the use of shunts
causes stenosis of the native coronary artery at the site of
application distal to the anastomosis.
Although, in our crude analysis, the left ITA grafts per-
formed better than the other grafts, it is interesting that
the multivariate analysis did not confirm this finding.
Even in the absence of randomized controlled trials, it is
widely accepted that the left ITA is the best available graft
material.30 Recent studies have not convincingly demon-
strated a similar advantage from using the biologically
similar right ITA compared with radial artery or vein graft
material for other coronary territories than LAD.31 Still,
caution should be taken about drawing too firm conclusions
from this incidental finding in the present study.
As we have reported earlier, a higher amount of perioper-
ative bleeding was found in OPCAB patients than in
CCABG patients in the DOORS study.4 This finding is in
contrast to the results of most earlier trials, which reported
that bleeding was reduced by avoiding cardiopulmonary
bypass.8-10 It can be suspected that this difference is
influenced by the higher dose of heparin used in the
OPCAB group in the present study. Because we did not
find that this drawback was balanced by a decrease in the
difference in graft patency between groups, we do not
recommend the practice of full perioperative
heparinization to be adopted. Whether dual antiplatelet
therapy should be administered to all patients undergoing
OPCAB and CCABG, and the optimal duration of such
therapy, if appropriate, requires further study. However,
dual antiplatelet therapy (aspirin and clopidogrel) is
recommended for 12 months after non-ST segment eleva-
tion acute coronary syndromes, that is, irrespective of coro-
nary bypass surgery during this period, in patients who are
not at increased risk of bleeding.32
In conclusion, in a randomized setting, we found that
OPCAB patients received fewer grafts and had inferior
graft patency than patients operated on-pump even with
identical heparinization protocols. We did not find that
the use of intracoronary shunts caused damage to the
native vessels. Binomial regression analysis showed that
the use of cardiopulmonary bypass, pedicled grafts, and
position on the LAD territory were positive predictors of
graft patency.Limitations
Only 56% of the patients who survived the first 6 months
were willing or able to undergo the follow-up coronary
angiography. As indicated above, some selection bias was
present with regard to the propensity of the patients togery c November 2014
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Dattend coronary angiography. However, propensity weight-
ing did not change the overall results or conclusions.
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TABLE E1. The propensity to attend follow-up was estimated using 2 different logistic models (including randomization group, age, sex, left main
coronary artery disease, left ventricular ejection fraction, triple vessel disease, previousmyocardial infarction, diabetes, hypertension, and smoking
status), which differed by either not allowing or allowing interaction between the randomization group and the other factors
Crude analysis Multiply adjusted analysis
RD CI low CI upper P value RD CI low CI upper P value
A: Allowing interaction between the randomization group and the other factors
CCABG (ref) (ref)
OPCAB 6.1 1.5 10.8 .01 5.2 0.8 9.5 .02
Territory
LAD (ref) (ref)
Cx 7.7 2.1 13.3 .01 6.1 1.3 13.6 .13
RCA 8.7 4.0 13.5 <.001 5.7 0.0 11.5 .048
Proximal anastomosis site
Aorta (ref) (ref)
Y graft 7.5 0.7 14.3 .03 5.6 0.02 13.4 .16
Pedicled 8.5 13.4 3.7 <.001 13.4 19.4 7.4 <.001
Graft material
Saphenous vein (ref) (ref)
Radial artery 4.1 3.7 12.1 .30 1.6 8.4 5.2 .52
Left internal thoracic artery 8.4 13.2 3.8 <.001 11.2 7.3 15.0 <.001
Right internal thoracic artery 3.0 10.7 16.8 .67 9.1 2.9 21.2 .14
Single graft (ref) (ref)
Sequential graft, second anastomosis 9.6 3.8 15.4 .001 7.8 1.2 14.3 .02
Sequential graft, third anastomosis 3.8 1.7 9.3 .18 1.5 7.9 4.8 .63
Sequential graft,>third anastomosis 12.3 4.5 20.2 .002 4.5 3.8 13.9 .26
No revision (ref) (ref)
Revision 4.1 8.3 16.5 .51 3.8 6.7 14.4 .47
B: Not allowing interaction between the randomization group and the other factors
CCABG (ref) (ref)
OPCAB 5.8 1.1 10.5 .02 5.1 0.8 9.5 .02
Territory
LAD (ref) (ref)
Cx 7.5 2.0 13.0 .01 5.4 1.7 12.5 .14
RCA 8.0 3.3 12.8 .001 4.7 0.9 10.4 .10
Proximal anastomosis site
Aorta (ref) (ref)
Y graft 6.2 0.01 13.2 .09 4.5 0.04 12.5 .27
Pedicled 8.4 13.2 3.6 <.001 15.3 21.5 9.1 <.001
Graft material
Saphenous vein (ref) (ref)
Radial artery 4.2 3.9 12.4 .31 0.2 6.9 6.5 .96
Left internal thoracic artery 8.1 12.9 3.3 .001 12.7 8.9 16.3 <.001
Right internal thoracic artery 2.9 11.0 16.8 .68 10.7 1.9 23.3 .10
Single graft (ref) (ref)
Sequential graft, second anastomosis 9.5 3.6 15.4 .002 7.7 0.9 14.5 .03
Sequential graft, third anastomosis 3.9 1.6 9.5 .16 0.9 7.4 5.4 .76
Sequential graft,>third anastomosis 12.5 4.7 20.2 .002 5.6 3.1 14.3 .21
No revision (ref) (ref)
Revision 7.0 6.3 20.2 .30 6.7 5.1 18.5 .26
RD, Risk difference (%); CI, confidence interval; CCABG, conventional coronary artery bypass grafting; OPCAB, off-pump coronary artery bypass; LAD, left anterior
descending; Cx, circumflex artery; RCA, right coronary artery.
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